Neuromuscular diseases

Citations 61-70 of 103 total displayed.

Past content (since Jun 1998):

Editorials
Poliomyelitis in the United States: The Final Chapter?

John F. Modlin
JAMA 2004; 292: 1749-1751. [Extract] [Full text] [PDF]  

JAMA Patient Page
Polio

Sharon Parmet; Tiffany J. Glass; Richard M. Glass
JAMA 2004; 292: 1780. [Extract] [Full text] [PDF]  

Letters
Intravenous Immunoglobulin and Quality of Life—Reply

Marinos C. Dalakas
JAMA 2004; 292: 1429-a-1430-a. [Extract] [Full text] [PDF]  

Letters
Intravenous Immunoglobulin and Quality of Life

Luca Padua; Irene Aprile; Pietro Caliandro; Costanza Pazzaglia; Pietro Tonali
JAMA 2004; 292: 1429. [Extract] [Full text] [PDF]  

Original Contributions
Effect of Galantamine Hydrobromide in Chronic Fatigue Syndrome: A Randomized Controlled Trial

C. V. Russell Blacker; David T. Greenwood; Keith A. Wesnes; Rosamund Wilson; Carol Woodward; Ian Howe; Tauhid Ali
JAMA 2004; 292: 1195-1204. [Abstract] [Full text] [PDF]  

Editorials
Pharmacotherapy of Chronic Fatigue Syndrome: Another Gallant Attempt

Stephen E. Straus
JAMA 2004; 292: 1234-1235. [Extract] [Full text] [PDF]  

The World in Medicine
Gene Therapy and ALS

Joan Stephenson
JAMA 2004; 291: 2809-c. [Extract] [Full text] [PDF]  

Clinical Reviews
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases

Marinos C. Dalakas
JAMA 2004; 291: 2367-2375. [Abstract] [Full text] [PDF]  

Medical News & Perspectives
Vaccine Rumors, Funding Shortfall Threaten to Derail Global Polio Eradication Efforts

Mike Mitka
JAMA 2004; 291: 1947-1948. [Extract] [Full text] [PDF]  

The World in Medicine
Polio Eradication Plan

Joan Stephenson
JAMA 2004; 291: 813-c. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11